Key result
Enoxaparin reduces inferior vena cava thrombus size ~61% in a mouse thrombosis model.
Why the study?
A rodent model that generates consistent venous thrombi in the presence of continuous blood flow to evaluate therapeutic agents for DVT was not available.
Answers are grounded in this paper and cite their sources.
The electrolytic inferior vena cava model in mice generates consistent venous thrombi with continuous blood flow, providing a reliable preclinical model for deep venous thrombosis research.
Several rodent models have been used to study deep venous thrombosis (DVT). However, a model that generates consistent venous thrombi in the presence of continuous blood flow, to evaluate therapeutic agents for DVT, is not available. Mice used in the present study were wild-type C57BL/6 (WT), plasminogen activator inhibitor-1 (PAI-1) knock out (KO) and Delta Cytoplasmic Tail (DCT). An electrolytic inferior vena cava (IVC) model (EIM) was used. A 25G stainless-steel needle, attached to a silver coated copper wire electrode (anode), was inserted into the exposed caudal IVC. Another electrode (cathode) was placed subcutaneously. A current of 250 muAmps over 15 minutes was applied. Ultrasound imaging was used to demonstrate the presence of IVC blood flow. Analyses included measurement of plasma soluble P-selectin (sP-Sel), thrombus weight (TW), vein wall morphometrics, P-selectin and Von Willebrand factor (vWF) staining, transmission electron microscopy (TEM), scanning electron microscopy (SEM); and the effect of enoxaparin on TW was evaluated. A current of 250 muAmps over 15 minutes consistently promoted thrombus formation in the IVC. Plasma sP-Sel was decreased in PAI-1 KO and increased in DCT vs. WT (WT/PAI-1: p=0.003, WT/DCT: p=0.0002). Endothelial activation was demonstrated by SEM, TEM, P-selectin and vWF immunohistochemistry and confirmed by inflammatory cell counts. Ultrasound imaging demonstrated thrombus formation in the presence of blood flow. Enoxaparin significantly reduced the thrombus size by 61% in this model. This EIM closely mimics clinical venous disease and can be used to study endothelial cell activation, leukocyte migration, thrombogenesis and therapeutic applications in the presence of blood flow.
No takes yet. Share an insight, caveat, or question.
Hawley et al. (2010) studied Deep venous thrombosis. Electrolytic inferior vena cava model (EIM) and Enoxaparin vs. Wild-type mice / Control was evaluated on Thrombus formation and size (61% reduction). An electrolytic inferior vena cava model consistently promoted thrombus formation in mice, and enoxaparin significantly reduced thrombus size by 61%.
Synapse has enriched 10 related papers. Consider them for comparative context: